title: Economic evaluation in clinical nephrology: part 2. Applying economic evaluations in clinical nephrology.
abstract: Our previous article described the principles of conducting an economic evaluation for evidence-based medical decision making. This article provides some tips for reading, critically appraising and applying the findings of an economic evaluation in clinical practice.
authors.affiliation: Centre for Kidney Research, The Children's Hospital at Westmead, New South Wales, Australia. germainw@chw.edu.au
authors.forename: Germaine
authors.initials: G
authors.lastname: Wong
authors.forename: Kirsten
authors.initials: K
authors.lastname: Howard
authors.forename: Jonathan C
authors.initials: JC
authors.lastname: Craig
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006302:Health Services Research / Q000191:economics*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000191:economics*; D018803:Models, Economic; D009398:Nephrology / Q000191:economics*; D018579:Patient Selection; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents